Skip to main content
No. of Recommendations: 2
The thing with EXAS is fears of competition, namely blood drawn tests that are being developed, have done nothing to stop the share price from marching upwards. Time and time again, I have been proven that "fears" of "potential" competition is not a reason to sell a stock. When competition actually starts taking a bite, that's when you have to reassess. That and them blaming a slowdown during the last flu season because of doctors being too busy with the flu, seemed a little odd to me. So congrats for hanging on. The more observations and case studies you have, the better your framework for evaluating companies going forward. I know EXAS is working on a lot of things too so I don't expect them to be a "one hit wonder" for long.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.